LAUSR

Ocular adverse events with immune checkpoint inhibitors

Sign Up to like & get
recommendations!
0 Published in 2019 at "Journal of Current Ophthalmology"

DOI: 10.1016/j.joco.2019.05.002

Abstract: Purpose To quantify the risk of ocular adverse events with immune checkpoint inhibitors (ICIs) as reported to the Food and Drug Administration (FDA). Methods Disproportionality analysis using data from U.S. FDA's Adverse Events Reporting System… read more here.

Keywords: immune checkpoint; checkpoint inhibitors; ocular adverse; adverse events ... See more keywords